Executive record

Charles Carter

Most recent record: Ovid Therapeutics Inc. CFO transition: Charles Carter to succeed Jeffrey Rona (named as the incoming officer), effective July 6, 2026. See Ovid Therapeutics Inc..

1 verified record

This page lists only verified filing records that name Charles Carter; it is not a career history. Corrections: the corrections page.